ACH
MRNA icon

ArrowMark Colorado Holdings’s Moderna MRNA Stock Holding History

ArrowMark Colorado Holdings’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-263,181
Closed -$3.85M – 333
2019
Q2 		$3.85M Buy
+263,181
New +$5.65M 0.04% 217
2019
Q1 		– Sell
-209,759
Closed -$3.2M – 333
2018
Q4 		$3.2M Buy
+209,759
New +$3.45M 0.03% 247

Other funds holding MRNA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
RWA
Ropes Wealth Advisors Boston, Massachusetts $515M AUM 21.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ArrowMark Colorado Holdings's MRNA Position: Q3 2019 in Review

ArrowMark Colorado Holdings sold out of Moderna (MRNA) in Q3 2019, closing a stake of 263,181 shares — an estimated $3.85M sold.

ArrowMark Colorado Holdings first reported a position in MRNA in Q4 2018 and held it in 2 quarters. The position peaked at $3.85M in Q2 2019. 136 funds tracked by Wall St. Rank hold MRNA as of Q3 2019.

  • ArrowMark Colorado Holdings reported no remaining Moderna position as of Q3 2019 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 263,181 Moderna shares in Q3 2019, an estimated $3.85M.
  • ArrowMark Colorado Holdings first reported a position in Moderna in Q4 2018 and held it in 2 quarters.
  • ArrowMark Colorado Holdings's Moderna position peaked at $3.85M in Q2 2019.
  • 136 funds tracked by Wall St. Rank held Moderna as of Q3 2019.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.